Find out more about Timothy Clay's experience
Timothy Clay's highlights
FEATURED Journal article
Phase 1, open-label, dose-escalation study on the safety, pharmacokinetics, and preliminary efficacy of intravenous Coxsackievirus A21 (V937), with or without pembrolizumab, in patients with advanced solid tumors.
Read moreTimothy Clay's selected work
The impact of the 2022 Ukraine/Russian conflict on cancer clinical trials.
Journal article
Acute effect of high-intensity interval aerobic exercise on serum myokine levels and resul..
Journal article
Patterns of immunotherapy-induced pneumonitis in patients with non-small-cell lung cancer:..
Journal article
Doctors' understanding of consent law
Journal article
Dilemmas in anticoagulation and use of inferior vena cava filters in venous thromboembolis..
Journal article
Metastatic seminoma in a 77-year-old man with a regressed primary tumour and concurrent hi..
Journal article
Timothy Clay's selected work
Scholarly Works
Displaying the 10 most recent scholarly works from 30 for Timothy Clay.
Credentials
Positions
Casual
Medical Education